Comparisons between Portosystemic Shunting Modalities in Patients with Liver Cirrhosis and Portal Hypertension

2017 ◽  
Vol 2 (1) ◽  
pp. 1-8
Author(s):  
Firuz Gafurovich Nazyrov ◽  
◽  
Castro-Benitez C ◽  
Andrey Vasilyevich Devyatov ◽  
Azam Khasanovich Babadjanov ◽  
...  
2016 ◽  
Vol 9 (3) ◽  
pp. 23-29
Author(s):  
FERUZ NAZYROV ◽  
◽  
ANDREY DEVYATOV ◽  
SHUKHRAT URAKOV ◽  
ELNAR NIGMATULLIN ◽  
...  

2020 ◽  
Vol 39 (3) ◽  
pp. 91-95
Author(s):  
Sergey A. Alentyev ◽  
Igor E. Onnicev ◽  
Igor Berlev ◽  
Anton L. Muzharovskiy

Nowadays the treatment of patients with malignant neoplasms of the abdominal organs against the background of decompensated liver cirrhosis is largely an unsolved problem. Complications of portal hypertension syndrome such as ascites, hypersplenism, recurrent bleeding from the veins of the esophagus prevent the implementation of radical surgical treatment. Low trauma of endovascular methods of treatment, low level of complications and mortality are the main advantages of interventional techniques that make it possible to prepare a patient with portal hypertension syndrome for further radical treatment of oncological disease. The presented clinical case describes the results of a combined approach to the treatment of a patient with complications of portal hypertension syndrome and a competing disease a giant tumor of the uterus. The patient was denied in surgical treatment for the neoplasm due to the presence of decompensated cirrhosis. Liver transplantation is not possible due to the presence of cancer. Transjugular intrahepatic portosystemic shunting led to relief of diuretic-resistant ascites, regression of the degree of esophageal varicose veins, which made it possible to remove the tumor with extirpation of the uterus with appendages. Up to now the observation period for the patient is more than 12 years (4 figs, bibliography: 7 refs).


Author(s):  
Ю.В. Хоронько ◽  
Д.В. Мартынов ◽  
Е.В. Косовцев ◽  
Ю.И. Лебедев

2019 ◽  
Vol 20 (17) ◽  
pp. 4161
Author(s):  
Ting Chang ◽  
Hsin-Ling Ho ◽  
Shao-Jung Hsu ◽  
Ching-Chih Chang ◽  
Ming-Hung Tsai ◽  
...  

Patients suffering from liver cirrhosis are often complicated with the formation of portosystemic collateral vessels, which is associated with the progression of a splanchnic hyperdynamic circulatory state. Alleviating pathological angiogenesis has thus been proposed to be a feasible treatment strategy. Indole-3-carbinol (C9H9NO, I3C) and 3,3′-diindolymethane (DIM), formed by the breakdown of glucosinolate glucobrassicin, are prevalent in cruciferous vegetables and have anti-angiogenesis properties. We aimed to evaluate their influences on portal hypertension, the severity of mesenteric angiogenesis, and portosystemic collaterals in cirrhosis. Sprague-Dawley rats with common bile duct ligation (CBDL)-induced liver cirrhosis or sham operation (surgical control) were randomly allocated to receive I3C (20 mg/kg/3 day), DIM (5 mg/kg/day) or vehicle for 28 days. The systemic and portal hemodynamics, severity of portosystemic shunting, mesenteric angiogenesis, and mesenteric proangiogenic factors protein expressions were evaluated. Compared to vehicle, both DIM and I3C significantly reduced portal pressure, ameliorated liver fibrosis, and down-regulated mesenteric protein expressions of vascular endothelial growth factor and phosphorylated Akt. DIM significantly down-regulated pErk, and I3C down-regulated NFκB, pIκBα protein expressions, and reduced portosystemic shunting degree. The cruciferous vegetable byproducts I3C and DIM not only exerted a portal hypotensive effect but also ameliorated abnormal angiogenesis and portosystemic collaterals in cirrhotic rats.


2014 ◽  
Vol 126 (9) ◽  
pp. 633-644 ◽  
Author(s):  
Shao-Jung Hsu ◽  
Sun-Sang Wang ◽  
I-Fang Hsin ◽  
Fa-Yauh Lee ◽  
Hui-Chun Huang ◽  
...  

Green tea polyphenol ameliorates the severity of portosystemic shunting and mesenteric angiogenesis via the suppression of HIF-1α, Akt activation and VEGF. Green tea polyphenol appears to be an appropriate agent to control portal hypertension-related complications via anti-angiogenenic effects.


2001 ◽  
Vol 120 (5) ◽  
pp. A224-A224
Author(s):  
A GUNNARSDOTTIR ◽  
E BJOMSSON ◽  
G RINGSTROM ◽  
M SIMREN ◽  
P STOTZER ◽  
...  

2019 ◽  
Vol 98 (8) ◽  
pp. 326-327 ◽  

Introduction: The umbilical vein can become recanalised due to portal hypertension in patients with liver cirrhosis but the condition is rarely clinically significant. Although bleeding from this enlarged vein is a known complication, the finding of thrombophlebitis has not been previously described. Case report: We report the case of a 62-year-old male with a history of liver cirrhosis due to alcoholic liver disease presenting to hospital with epigastric pain. A CT scan of the patient’s abdomen revealed a thrombus with surrounding inflammatory changes in a recanalised umbilical vein. The patient was managed conservatively and was discharged home the following day. Conclusion: Thrombophlebitis of a recanalised umbilical vein is a rare cause of abdominal pain in patients with liver cirrhosis.


Sign in / Sign up

Export Citation Format

Share Document